Antoine Yver - Aug 1, 2022 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Signature
/s/Gregory Weinhoff, attorney-in-fact
Stock symbol
CNTA
Transactions as of
Aug 1, 2022
Transactions value $
-$46,405
Form type
4
Date filed
8/3/2022, 06:00 PM
Previous filing
Jul 20, 2022
Next filing
Sep 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNTA Ordinary Shares Sale -$46.4K -10.4K -1.29% $4.45 800K Aug 1, 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 The sales reported in this Form 4 represents the number of shares sold by the Reporting Person for the purpose of covering tax withholding obligations in connection with the vesting of the restricted shares pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 17, 2021, as amended, and does not represent a discretionary trade by the Reporting Person.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.395 to $4.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.